Altered expression of extracellular matrix in human-cytomegalovirus-infected cells and a human artery organ culture model to study its biological relevance

Intervirology

Volumn 42, Issue 5-6, 1999, Pages 357-364

  Schaarschmidt, Peter ^a   Reinhardt, Barbara ^a   Michel, Detlef ^a   Vaida, Bianca ^a   Mayr, Klaus ^a   Lüske, Anke ^a   Baur, Regine ^a   Gschwend, Jürgen ^a   Kleinschmidt, Klaus ^a   Kountidis, Margaritis ^b   Wenderoth, Ulrich ^b   Voisard, Rainer ^a   Mertens, Thomas ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Universitätsklinikum Ulm ^*

Author keywords

Cytopathic effect; Extracellular matrix; HCMV; Human renal artery organ culture

Indexed keywords

BETA ACTIN; MESSENGER RNA;

CELL ADHESION; CELL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; NONHUMAN; NORTHERN BLOTTING; ORGAN CULTURE; PRIORITY JOURNAL; RENAL ARTERY;

HUMAN HERPESVIRUS 5;

EID: 0343550340     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053972     Document Type: Conference Paper

References (48)

1. Adam E, Melnick JL, Probstfield JL, Petrie BL, Burck J, Bailey KR, McCollum CH, Debakey ME: High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;ii:291-293.
2. Melnick JL, Adam E, Debakey ME: Possible role of cytomegalovirus in atherogenesis. JAMA 1990;263:2204-2207.
3. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-3566.
4. Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr (eds): CMV-Related Immunopathology, Monogr Virol. Basel, Karger, 1998, vol 21, pp 158-172.
5. Grefte A, Van der Giessen M, Van Son W, The TH: Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 1993;167: 270-277.
6. Mocarski ES, Fields BN, Knipe DM, Howley PM (eds): Cytomegaloviruses and their replication. Virology, ed 3. Philadelphia, Lippincott-Raven, 1996, vol 76, pp 2447-2492.
7. Swanson RGE, Wong SC: Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility. Virology 1998;240: 338-348.
8. Ustinov JA, Loginov RJ, Bruggeman CA, Van der Meide PH, Hayry PJ, Lautenschlager IT: Cytomegalovirus induces class II expression in rat heart endothelial cells. J Heart Lung Transplant 1993;12:644-651.
9. Knight DA, Waldman WJ, Sedmak DD: E-selectin, VCAM-1, and ICAM-1 expression on cytomegalovirus-infected human arterial endothelial cells. 6th Int CMV Workshop, Orange Beach, 1997.
10. Sedmak DD, Guglielmo AM, Knight DA, Birmingham D, Huang EH, Waldman WJ: Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 1994;144:683-692.
11. Voisard R, Jensch V, Baur R, Hoher M, Hombach V: A coronary porcine organ culture system for studies of postangioplasty cell proliferation. Coron Artery Dis 1995;6:657-665.
12. Yurochko AD, Hwang ES, Rasmussen L, Keay S, Pereira L, Huang ES: The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol 1997;71: 5051-5059.
13. Liu B, Stinski MF: Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol 1992;66:4434-4444.
14. Pizzorno MC, O'Hare P, Sha L, LaFemina RL, Hayward GS: Trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus. J Virol 1988;62:1167-1179.
15. Malone CL, Vesole DH, Stinski MF: Transactivation of a human cytomegalovirus early promoter by gene products from the immediateearly gene IE2 and augmentation by IE1: Mutational analysis of the viral proteins. J Virol 1990;64:1498-1506.
16. Stenberg RM, Fortney J, Barlow SW, Magrane BP, Nelson JA, Ghazal P: Promoter-specific transactivation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol 1990;64:1556-1565.
17. Chee MS, Satchwell SC, Preddie E, Weston KM, Barrell BG: Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 1990;344:774-777.
18. Welch AR, McGregor LM, Gibson W: Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed. J Virol 1991;65:3915-3918.
19. Jault FM, Jault JM, Ruchti F, Fortunato EA, Clark C, Corbeil J, Richman DD, Spector H: Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 1995;69:6697-6704.
20. Bresnahan WA, Boldogh I, Thompson EA, Albrecht T: Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virol 1996;224:150-160.
21. Lu M, Shenk T: Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol 1996;70:8850-8857.
22. Lu M, Shenk T: Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J Virol 1999;73:676-683.
23. Dittmer D, Mocarski ES: Human cytomegalovirus infection inhibits G1/S transition. J Virol 1997;71:1629-1634.
24. Hirai K, Furukawa T, Plotkin SA: Induction of DNA polymerase in WI-38 and guinea pig cells infected with human cytomegalovirus (HCMV). Virology 1976;70:251-255.
25. Isom HC: Stimulation of ornithine decarboxylase by human cytomegalovirus. J Gen Virol 1979;42:265-278
26. Boldogh I, AbuBakar S, Albrecht T: Activation of proto-oncogenes: An immediate early event in human cytomegalovirus infection. Science 1990;247:561-564.
27. Santomenna LD, Colberg Poley AM: Induction of cellular hsp70 expression by human cytomegalovirus. J Virol 1990;64:2033-2040.
28. Sambucetti LC, Cherrington JM, Wilkinson GW, Mocarski ES: NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J 1989;8:4251-4258.
29. Grundy JE. Downes KL: Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology 1993;78:405-412.
30. Warren AP, Owens CN, Borysiewicz LK, Patel K: Down-regulation of integrin alpha 1/beta 1 expression and association with cell rounding in human cytomegalovirus-infected fibroblasts. J Gen Virol 1994;75:3319-3325.
31. Ihara S, Saito S, Watanabe Y: Suppression of fibronectin synthesis by an early function(s) of human cytomegalovirus. J Gen Virol 1982;59: 409-413.
32. Muganda P, Mendoza O, Hernandez J, Qian Q: Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J Virol 1994;68:8028-8034.
33. Almeida GD, Porada CD, St. Jeor S, Ascensao JL: Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994; 83:370-376.
34. Almeida Porada G, Porada CD, Shanley JD, Ascensao JL: Altered production of GM-CSF and IL-8 in cytomegalovirus-infected, IL-1-primed umbilical cord endothelial cells. Exp Hematol 1997;25:1278-1285.
35. Michelson S, Dal Monte P, Zipeto D, Bodahi B, Laurent L, Oberlin E, Arenzana-Seisdedos F, Virelizier J-L, Landini MP: Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J Virol 1997;71: 6495-6500.
36. Yurochko AD, Kowalik TF, Huong SM, Huang ES: Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 1995;69:5391-5400.
37. Yurochko AD, Mayo MW, Poma EE, Baldwin AS Jr, Huang ES: Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. J Virol 1997; 71:4638-4648.
38. Phillips AJ, Tomasec P, Wang ECY, Wilkinson GWG, Borysiewicz LK: Human cytomegalovirus infection downregulates expression of the cellular aminopeptidases CD10 and CD13. Virology 1998;250:350-358.
39. Zhu H, Cong J-P, Mamtora G, Gingeras T, Shenk T: Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays. Proc Natl Acad Sci USA 1998;95:14470-14475.
40. Zhu H, Cong J-P, Shenk T: Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs. Proc Natl Acad Sci USA 1997; 94:13985-13990.
41. Ayad S, Boot-Handford R, Humphries MJ, Kadler KE, Shuttleworth A: The extracellular matrix facts book. New York. Academic Press, 1994.
42. Streuli CH: Extracellular matrix and gene expression in mammary epithelium. Semin Cell Biol 1993;4:203-212.
43. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynck R: Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol 1993;120:253-260.
44. Grefte A, Blom N, Van der Giessen M, Van Son W, The TH: Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: Evidence for virus production and endothelial origin. J Infect Dis 1993;168:1110-1118.
45. Voisard R, V Eicken J, Baur R, Gschwend JE, Wenderoth U, Kleinschmidt K, Hombach V, Höher M: A human arterial organ culture model of postangioplasty restenosis: Results up to 56 days after ballooning. Atherosclerosis 1999; 144:123-134.
46. Pande H, Terramani T, Tressel T, Churchill MA, Hawkins GG, Zaia JA: Altered expression of fibronecting gene in cells infected with human cytomegalovirus. J Virol 1990;64:1366-1369.
47. Shahgasempour S, Woodroffe SB, Sullivan-Tailyour G, Garnett HM: Alteration in the expression of endothelial cell integrin receptors alpha 5 beta 1 and alpha 2 beta 1 and alpha 6 beta 1 after in vitro infection with a clinical isolate of human cytomegalovirus. Arch Virol 1997;142:125-138.
48. Cinatl J Jr, Kotchetkow R, Scholz M, Cinatl J, Vogel JU, Driever PH, Doerr HW: Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am J Pathol 1999;155:285-292.